As Pcm (PCMI) Valuation Declined, Weber Alan W Increased by $980,000 Its Holding; Flow Traders Us Boosted Its Novo Nordisk A/S (NVO) Stake by $478,992; Share Value Rose

February 15, 2018 - By Darrin Black

Weber Alan W increased its stake in Pcm Inc (PCMI) by 272.37% based on its latest 2017Q3 regulatory filing with the SEC. Weber Alan W bought 70,000 shares as the company’s stock declined 32.07% while stock markets rallied. The institutional investor held 95,700 shares of the consumer services company at the end of 2017Q3, valued at $1.34M, up from 25,700 at the end of the previous reported quarter. Weber Alan W who had been investing in Pcm Inc for a number of months, seems to be bullish on the $95.72 million market cap company. The stock increased 0.31% or $0.025 during the last trading session, reaching $8.125. About 28,518 shares traded. PCM, Inc. (NASDAQ:PCMI) has risen 87.13% since February 15, 2017 and is uptrending. It has outperformed by 70.43% the S&P500.

Flow Traders Us Llc increased its stake in Novo Nordisk A/S (NVO) by 183.54% based on its latest 2017Q3 regulatory filing with the SEC. Flow Traders Us Llc bought 9,979 shares as the company’s stock rose 15.20% with the market. The institutional investor held 15,416 shares of the major pharmaceuticals company at the end of 2017Q3, valued at $742,000, up from 5,437 at the end of the previous reported quarter. Flow Traders Us Llc who had been investing in Novo Nordisk A/S for a number of months, seems to be bullish on the $118.47B market cap company. The stock increased 0.93% or $0.47 during the last trading session, reaching $51.27. About 598,113 shares traded. Novo Nordisk A/S (NYSE:NVO) has declined 23.93% since February 15, 2017 and is downtrending. It has underperformed by 40.63% the S&P500.

Among 15 analysts covering Novo Nordisk (ADR) (NYSE:NVO), 7 have Buy rating, 0 Sell and 8 Hold. Therefore 47% are positive. Novo Nordisk (ADR) had 21 analyst reports since August 28, 2015 according to SRatingsIntel. The company was downgraded on Monday, October 31 by DNB Markets. The stock has “Market Perform” rating by Leerink Swann on Friday, August 28. The rating was upgraded by Jyske Bank on Monday, October 19 to “Strong Buy”. The rating was upgraded by Bank of America to “Neutral” on Wednesday, September 6. The firm has “Underperform” rating given on Friday, October 28 by Bank of America. The rating was upgraded by J.P. Morgan to “Hold” on Friday, December 29. The stock has “Conviction Buy” rating by Goldman Sachs on Monday, February 15. On Friday, December 29 the stock rating was upgraded by JP Morgan to “Neutral”. The firm earned “Neutral” rating on Friday, September 23 by Piper Jaffray. The stock of Novo Nordisk A/S (NYSE:NVO) has “Hold” rating given on Friday, August 28 by Zacks.

Flow Traders Us Llc, which manages about $928.44 million US Long portfolio, decreased its stake in United States Short Oil Fund L (DNO) by 5,609 shares to 4,705 shares, valued at $311,000 in 2017Q3, according to the filing. It also reduced its holding in Proshares Short Euro Etf (EUFX) by 11,705 shares in the quarter, leaving it with 7,178 shares, and cut its stake in Direxion Daily Junior Gold Min.

Among 4 analysts covering PCM Inc (NASDAQ:PCMI), 4 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. PCM Inc had 8 analyst reports since July 21, 2016 according to SRatingsIntel. The firm has “Buy” rating by TH Capital given on Thursday, October 27. The stock of PCM, Inc. (NASDAQ:PCMI) has “Neutral” rating given on Thursday, August 25 by TH Capital. B. Riley & Co maintained PCM, Inc. (NASDAQ:PCMI) on Tuesday, November 7 with “Buy” rating. The stock of PCM, Inc. (NASDAQ:PCMI) earned “Neutral” rating by Roth Capital on Thursday, August 25. The stock has “Buy” rating by Roth Capital on Thursday, July 21. As per Thursday, October 27, the company rating was upgraded by Roth Capital.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


>